SCHEMBL968523

SCHEMBL968523

O=C(CN1CCc2cn3nccc3nc2C1)N1CCN(C2CCC2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 4/20 0.39
HRH3 Q9Y5N1 5/20 0.38
KCNH2 Q12809 2/20 0.38
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CBX7 O95931 3/20 0.36
CDYL2 Q8N8U2 3/20 0.36
CDYL Q9Y232 3/20 0.36
CDY1; CDY1B Q9Y6F8 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 1/20 0.35
ENPP2 Q13822 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL967179 0.92 PARP1 (0.40) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1018644 0.77 ALDH1A1 (0.59) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1014872 0.77 NAMPT (0.49) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1020057 0.76 ALDH1A1 (0.39) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1017157 0.76 KDM4E (0.42) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1018352 0.74 HRH3 (0.60) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1018078 0.73 HRH3 (0.38) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1016304 0.73 HRH3 (0.43) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1017527 0.73 HRH3 (0.41) PARP1ALDH1A1KDM4EHRH3KCNH2
SCHEMBL1014992 0.73 TMEM97 (0.42) PARP1ALDH1A1KDM4EHRH3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US claimed
EP-2162451-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES Neurogen Corporation (US) 2010-03-17 EP claimed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO claimed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
EP-2162451-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES Neurogen Corporation (US) 2010-03-17 EP disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 PARP1 2898/4885ALDH1A1 812/4885KDM4E 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.